Thirdwayv Applauds Glas for Receiving FDA Approval of G2 Flavored ENDS with Advanced Age-Gating Technology

Thirdwayv Applauds Glas for FDA Approval of G2 Flavored ENDS Products

In an exciting development for the vaping industry, Thirdwayv Inc. has expressed its congratulations to Glas Inc. for securing FDA authorization for their innovative G2 flavored electronic nicotine delivery system (ENDS) products. This landmark approval marks a significant milestone, as it positions the G2 flavored ENDS at the forefront of FDA-regulated alternatives to traditional combustible cigarettes.

According to the announcement made on June 8, 2026, the FDA's approval was achieved through the rigorous premarket tobacco product application (PMTA) process, showcasing Glas's commitment to safety and compliance with federal regulations. Thirdwayv emphasized the essential role its proprietary age-gating and counterfeit-detection technology played in this groundbreaking success.

The Role of Age-Gating Technology

Central to the G2 system is Thirdwayv's patented VitaProtect™ technology, which mandates that users authenticate their age and identity via a government-issued ID before pairing the device with their smartphones through Bluetooth. This proactive measure ensures that only verified adults can operate the device. Furthermore, Thirdwayv’s Proximity Lock technology adds another layer of security by preventing the G2 from functioning when it is not in close range of the paired phone. Regular biometric check-ins are also required to confirm that the registered user remains the device's operator, drastically reducing the chances of underage access.

To complement its security features, VitaProtect™ cryptographically authenticates G2 pods, effectively safeguarding against counterfeit products that may pollute the market. The FDA's detailed review concluded that Glas successfully demonstrated its G2 system's ability to mitigate youth access while aiding adult smokers in transitioning away from traditional cigarettes.